Cargando…
High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis
BACKGROUND: Response prediction of certain biologic agents for the treatment of rheumatoid arthritis (RA) remains an unmet need in real-world clinical practice. The contribution of patient-reported components to the 28-joint Disease Activity Score (DAS28) was termed DAS28-P and investigated as a pre...
Autores principales: | Lee, Jeong Seok, Ahmad, Harris, Shim, Seung-Cheol, Bae, Sang-Cheol, Song, Yeong Wook, Lee, Eun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525138/ https://www.ncbi.nlm.nih.gov/pubmed/30484084 http://dx.doi.org/10.1007/s40271-018-0347-z |
Ejemplares similares
-
Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008) -
Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006) -
Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011) -
Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013) -
Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
por: Köller, Marcus D.
Publicado: (2007)